News

yan zhang

Y. Zhang joins Chairs’ Interdepartmental Research Collaboration (CIRC) meeting at VCU School of Medicine

March 10, 2025

Yan Zhang, Ph.D., is director of the Center for Drug Discovery.

xiadong wang

Wang visits VCU Department of Medicinal Chemistry

March 7, 2025

Xiaodong Wang, Ph.D., is a professor at the University of North Carolina at Chapel Hill.

Shijun Zhang, Ph.D., a professor in the School of Pharmacy, is pioneering drug discovery research focused on an essential component of the immune system. (Christopher Kendall)

Alzheimer’s, antennas and AI are highlighted in VCU faculty research receiving new Commercialization Fund awards

Feb. 19, 2025

Five projects are selected in the latest round of funding that helps bring campus innovation to the marketplace.

binghe wang

Wang leads recent seminar at the Center for Drug Discovery

Feb. 18, 2025

The title of his seminar was “Defying Conventional Wisdom: Developing Carbon Monoxide as a Therapeutic Agent."

yan zhang

Zhang visits National Institute on Drug Abuse Intramural Research Program

Feb. 4, 2025

Zhang is the director of the VCU Center for Drug Discovery.

Shijun Zhang

Shijun Zhang named 2024 NIRA Scholar

Nov. 25, 2024

Shijun Zhang, Ph.D. becomes the third VCU Pharmacy faculty member to be named a NIRA Scholar.

yan zhang

Yan Zhang appointed as director of VCU's Center for Drug Discovery

Oct. 5, 2024

This week, Yan Zhang, Ph.D., was named Director of VCU's Center for Drug Discovery, formerly known as the Institute for Structural Biology, Drug Discovery and Development.

martin safo

Safo receives R61/R33 grant for pre-trial studies

Oct. 1, 2024

Martin Safo, Ph.D.'s anti-sickling agent ILX002 has been received for pre-clinical and clinical development by the NHLBI under the CATALYZE Drug Development Program.

yan zhang

Zhang receives VCU Breakthrough Fund grant

Oct. 1, 2024

The title of his grant is "Lysophosphatidic acid (LPA) signaling in CNS myelination and myelin repair."

jiong li

Jiong Li awarded five-year R01 grant

Oct. 1, 2024

The title of his grant is "FOSL1-super-enhancers define cisplatin-enriched cancer stem cells in HNSCC."